Pfizer has signed a three-year agreement with Genologics for the latter to provide informatics solutions to the former's research labs.Under the terms of the agreement, GenoLogics will provide an enterprise-enabled lab and data management system to capture, contextualise and integrate science data in multiple locations worldwide. In addition to the ability to leverage data standards across labs by virtue of a common informatics platform, GenoLogics will provide Pfizer with the tools to enable web-based collaboration, bioinformatics pipelining, auditability and reporting of cross-science data.
'We are excited to be working with Pfizer on a global basis and supporting their research centres with informatics solutions that we can customise by lab regardless of their science,' said Michael Ball, CEO of GenoLogics. 'Expanding our client base to include the world's largest pharmaceutical company is a significant milestone for GenoLogics and one that reinforces how our collaborative approach with clients ensures we deploy solutions that enable our client's success.'
'We required a vendor that provides a highly flexible and configurable solution that can be customised for a wide range of workflows and ever-changing technologies that are employed at our research centres,' said Giles Day, head, BBC Informatics at Pfizer. 'The GenoLogics informatics solution can be customised at the lab level, including instrument integrations and data imports, while allowing us to analyse data across sciences and labs.'
